Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed5
Other1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT06070116Phase 2Active Not Recruiting
Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis
Onchocerca InfectionOnchocercal Subcutaneous NoduleOnchocerciasis+2 more
PrincipalinvestigatorStart date: 2024-04-05
NCT04188301Phase 2Completed
Safety and Efficacy of IDA for Onchocerciasis
Onchocerciasis
PrincipalinvestigatorStart date: 2019-12-06
NCT03517462Not ApplicableCompleted
Ocular Changes After Ivermectin - (DOLF IVM/Oncho)
Onchocerciasis
PrincipalinvestigatorStart date: 2018-08-06
NCT03352206Completed
Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis
Lymphatic Filariases
PrincipalinvestigatorStart date: 2017-10-18
NCT03177993Not ApplicableCompleted
Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji
ImpetigoLymphatic FilariasesScabies+1 more
PrincipalinvestigatorStart date: 2017-07-13

Research Network

Collaboration Network

7 collaborators·9 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Christopher King, MD PhD

Case Western Reserve University

Similar
3 trials

Shared therapeutic areas:

Elephantiasis, FilarialImpetigoOnchocerciasis+2 more

Worked with same sponsors:

Case Western Reserve UniversityIndian Council of Medical Research+4 more
Collaborated on 3 trials
Similarity Score62%

Peter Fischer, PhD

Washington University School of Medicine

Similar
1 trials

Shared therapeutic areas:

Onchocerca InfectionOnchocercal Subcutaneous NoduleOnchocerciasis+2 more

Worked with same sponsors:

National Public Health Institute of LiberiaWashington University School of Medicine
Collaborated on 1 trial
Similarity Score54%

Patrick Kpanyen, PhD

National Public Health Institute of Liberia

Similar
1 trials

Shared therapeutic areas:

Onchocerca InfectionOnchocercal Subcutaneous NoduleOnchocerciasis+2 more

Worked with same sponsors:

National Public Health Institute of LiberiaWashington University School of Medicine
Collaborated on 1 trial
Similarity Score54%

Andrew Steer, PhD

Murdoch Childrens Research Institute

Moderately Similar
1 trials

Shared therapeutic areas:

ImpetigoElephantiasis, FilarialScabies+1 more

Worked with same sponsors:

Murdoch Childrens Research InstituteThe Task Force for Global Health+1 more
Collaborated on 1 trial
Similarity Score44%

Nicholas Opoku, MB, CHB, MSC

University of Health and Allied Sciences, Hohoe, Ghana

Related
1 trials

Shared therapeutic areas:

Onchocerciasis

Worked with same sponsors:

Case Western Reserve UniversityUniversity of Health and Allied Sciences+1 more
Collaborated on 1 trial
Similarity Score14%

Christopher King, MD, PhD

Case Western Reserve University

Related
1 trials

Shared therapeutic areas:

Onchocerciasis

Worked with same sponsors:

Case Western Reserve UniversityUniversity of Health and Allied Sciences+1 more
Collaborated on 1 trial
Similarity Score14%

James W Kazura, MD

Case Western Reserve University

Related
2 trials

Shared therapeutic areas:

Elephantiasis, FilarialOnchocerciasis
Similarity Score7%

Colin J Parker, MBBS

Australasian College of Dermatologists

Related
1 trials

Shared therapeutic areas:

ImpetigoScabies

Worked with same sponsors:

Murdoch Childrens Research Institute
Similarity Score7%

Thomas B Nutman, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
9 trials

Shared therapeutic areas:

Elephantiasis, FilarialOnchocerciasis
Similarity Score7%

Bart Currie, MBBS, DTM&H

Menzies School of Health Research

Related
1 trials

Shared therapeutic areas:

ImpetigoScabies

Worked with same sponsors:

Murdoch Childrens Research Institute
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT06070116Phase 2PrincipalInvestigator

Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis

Onchocerca InfectionOnchocercal Subcutaneous NoduleOnchocerciasis+2 more
Active Not Recruiting
NCT04188301Phase 2PrincipalInvestigator

Safety and Efficacy of IDA for Onchocerciasis

Onchocerciasis
Completed
NCT03517462Not ApplicablePrincipalInvestigator

Ocular Changes After Ivermectin - (DOLF IVM/Oncho)

Onchocerciasis
Completed
NCT03352206PrincipalInvestigator

Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

Lymphatic Filariases
Completed
NCT03177993Not ApplicablePrincipalInvestigator

Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji

ImpetigoLymphatic FilariasesScabies+1 more
Completed
NCT02899936Not ApplicablePrincipalInvestigator

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis

Lymphatic Filariasis
Completed

All 6 trials loaded